Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives $36.20 Consensus Target Price from Analysts
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) have received an average recommendation of “Hold” from the five research firms that are currently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month […]
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) have received an average recommendation of “Hold” from the five research firms that are currently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month […]
